Allergan Alphagan exclusivity threatened
Allergan expects an expedited appeal in patent infringement suit against Alcon over glaucoma agent Alphagan could be heard before the end of the year, prior to generic approvals. Federal Circuit Court of Appeal grants Alcon's motion for summary judgment. Allergan does not expect an ANDA for generic brimonidine tartrate ophthalmic solution until the first quarter 2003...
You may also be interested in...
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
Company is confident that data readout from pivotal trial could be ready before the end of 2020.
Cognoa said it will submit its AI-powered digital app for early detection of autism for de novo clearance with the US FDA. See what the company’s senior medical director of clinical adoption said about it here.